Feature|Articles|May 22, 2026
Inside the FDA's Commissioner's National Priority Voucher Program: Promise, Pressure, and Operational Reality
Author(s)Andy Studna, Senior Editor
The CNPV program has compressed drug review timelines to as little as one to two months for qualifying sponsors, but succeeding under that pressure requires a fundamental rethink of how development teams plan, communicate, and execute.
Advertisement
Advertisement
When the FDA
Advertisement
Advertisement
